Toxic neuropathies.
Rossor AM, Manji H.
Curr Opin Neurol. 2023 Oct 1;36(5):402-409. doi: 10.1097/WCO.0000000000001193. Epub 2023 Aug 2.
Agomelatine-induced hepatotoxicity.
Štuhec M.
Wien Klin Wochenschr. 2013 Apr;125(7-8):225-6. doi: 10.1007/s00508-013-0344-0. Epub 2013 Mar 22.
[Effect of acetamide on histopathology in cerebral cortex of rats with tetramine poisoning].
Wang X, Gao H, Yao D, Tian Y, Su J, Zhang H, Sun C, Shi H.
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2014 Apr;32(4):289-92.
[Levetiracetam hepatitis].
Gavilán JC, Bermúdez F, Romero M, González Santos P.
Med Clin (Barc). 2004 Jan 17;122(1):38. doi: 10.1016/s0025-7753(04)74132-9.
Linezolid-induced serotonin syndrome.
Gupta V, Karnik ND, Deshpande R, Patil MA.
BMJ Case Rep. 2013 Mar 18;2013:bcr2012008199. doi: 10.1136/bcr-2012-008199.
In vivo protection studies of bis-quaternary 2-(hydroxyimino)- N-(pyridin-3-yl) acetamide derivatives (HNK oximes) against tabun and soman poisoning in Swiss albino mice.
Kumar P, Swami D, Nagar DP, Singh KP, Acharya J, Karade HN, Yadav R.
Hum Exp Toxicol. 2017 Dec;36(12):1270-1285. doi: 10.1177/0960327116685888. Epub 2017 Jan 12.
Levetiracetam and psychosis.
Rodríguez-Toledo S, Trebbau-López H, Reyes-Molón L, del Río-Vega J.
Actas Esp Psiquiatr. 2012 Jan-Feb;40(1):49. Epub 2012 Jan 1.
Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS).
Kamitaki BK, Minacapelli CD, Zhang P, Wachuku C, Gupta K, Catalano C, Rustgi V.
Epilepsy Behav. 2021 Apr;117:107832. doi: 10.1016/j.yebeh.2021.107832. Epub 2021 Feb 21.
Choice of approaches in developing novel medical countermeasures for nerve agent poisoning.
Myhrer T, Aas P.
Neurotoxicology. 2014 Sep;44:27-38. doi: 10.1016/j.neuro.2014.04.011. Epub 2014 May 9.
The safety of levetiracetam.
Sirsi D, Safdieh JE.
Expert Opin Drug Saf. 2007 May;6(3):241-50. doi: 10.1517/14740338.6.3.241.
